CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response

Annals of Medicine

Volumn 36, Issue 5, 2004, Pages 347-354

  Moestrup, Søren K ^a   Moller, Holger J ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CD163; Haptoglobin; Heme; Hemoglobin; Inflammation; Macrophage; Sepsis

Indexed keywords

ANTIGEN; CD163 ANTIGEN; HAPTOGLOBIN; HEMOGLOBIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; BIOLOGICAL MONITORING; CROSS LINKING; DIAGNOSTIC VALUE; DOWN REGULATION; ENDOCYTOSIS; GENE DUPLICATION; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE ACTIVATION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PLASMA CLEARANCE; PRIORITY JOURNAL; REVIEW; SOLUBILIZATION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CYTOKINES; HEMOGLOBINS; HUMANS; MACROPHAGES; MONOCYTES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 4544246612     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890410033171     Document Type: Review

References (53)

1. Bunn HF, Rosse W. Hemolytic anemias and acute blood loss. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo JL, Jameson JL, editors. Harrison's Principles of Internal Medicine, 15th Edn. New York: McGraw-Hill; 2003:681-91.
2. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201.
3. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003;24:449-55.
4. Bowman BH, Barnett DR, Lum JB, Yang FM. Haptoglobin. Methods Enzymol 1988;163:452-74.
5. Wejman JC, Hovsepian D, Wall JS, Hainfeld JF, Greer J. Structure and Assembly of Haptoglobin Polymers by Electron-Microscopy. J Mol Biol 1984;174:343-68.
6. Wejman JC, Hovsepian D, Wall JS, Hainfeld JF, Greer J. Structure of Haptoglobin and the Haptoglobin Hemoglobin Complex by Electron-Microscopy. J Mol Biol 1984;174:319-41.
7. Law SKA, Micklem KJ, Shaw JM, Zhang XP, Dong Y, Willis AC, et al. A New Macrophage Differentiation Antigen Which Is A Member of the Scavenger Receptor Superfamily. Eur J Immunol 1993;23:2320-5.
8. Pulford K, Micklem K, McCarthy S, Cordell J, Jones M, Mason DY. A Monocyte Macrophage Antigen Recognized by the 4 Antibodies Ghi/61, Ber-Mac3, Ki-M8 and Sm4. Immunology 1992;75:588-95.
9. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209-12.
10. Grønlund J, Vitved L, Lausen M, Skjødt K, Holmskov U. Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages. J Immunol 2000;165:6406-15.
11. Bowen MA, Aruffo AA, Bajorath J. Cell surface receptors and their ligands: In vitro analysis of CD6-CD166 interactions. Proteins 2000;40:420-8.
12. Horn IR, Nielsen MJ, Madsen M, Jacobsen C, Graversen JH, Moestrup SK. Generation of a haptoglobin-hemoglobin complex-specific Fab antibody blocking the binding of the complex to CD163. Eur J Haematol 2003;71:289-93.
13. Fass D, Blacklow S, Kim PS, Berger JM. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 1997;388:691-3.
14. Pratt DS, Kaplan MM. Jaundice. In: Braunvvald E, Fauci AS, Kasper DL, Hauser SL, Longo JL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 15th edn. New York: McGraw-Hill; 2001:255-9.
15. Levy AP, Jablonski K, Resnick HE, Lee ET, Best LT, Howard BV. Haptoglobin phenotype and the risk of cardiovascular disease in individuals with diabetes: The Strong Heart Study. Circulation 2001;104:3.
16. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
17. Delanghe JR, Langlois MR. Haptoglobin polymorphism and body iron stores. Clin Chem Lab Med 2002;40:212-6.
18. Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res 2003;92:1193-200.
19. Ritter M, Buechler C, Kapinsky M, Schmitz G. Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C. Eur J Immunol 2001;31:999-1009.
20. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000;67:97-103.
21. Van den Heuvel MM, Tensen CP, van As JH, Van den Berg TK, Fluitsma DM, Dijkstra CD, et al. Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999;66:858-66.
22. Schaer DJ, Boretti FS, Schoedon G, Schaffner A. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Br J Haematol 2002;119:239-43.
23. Ratcliffe NR, Kennedy SM, Morganelli PM. Immunocytochemical detection of Fc gamma receptors in human atherosclerotic lesions. Immunol Lett 2001;77:169-74.
24. Fonseca JE, Edwards JCW, Blades S, Gouldin NJ. Macrophage subpopulations in rheumatoid synovium - Reduced CD163 expression in CD4+ T lymphocyte-rich microenviroments. Arthritis Rheum 2002;46:1210-6.
25. Baeten D, Demetter P, Cuvelier CA, Kruithof E, Van Damme N, De Vos M, et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002;196:343-50.
26. Philippidis P, Mason JC, Evans B, Nadra I, Taylor KM, Haskard DO, et al. The hemoglobin scavenger receptor CD163 on human macrophages is linked to athero-protective IL-10 and HO-1 effector pathways. Atherosclerosis 2003;170: S14.
27. Zwadlo G, Voegeli R, Osthoff KS, Sorg C. A Monoclonal-Antibody to A Novel Differentiation Antigen on Human Macrophages Associated with the Down-Regulatory Phase of the Inflammatory Process. Exp Cell Biol 1987;55:295-304.
28. Hogger P, Dreier J, Droste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998;161: 1883-90.
29. Sulahian TH, Hogger P, Wardwell K, Wardwell K, Goulding NJ, Sorg C, et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. FASEB J 2000;14: A1143.
30. Zwadloklarwasser G, Bent S, Haubeck HD, Sorg C, Schmutzler W. Glucocorticoid-Induced Appearance of the Macrophage Subtype Rm 3/1 in Peripheral-Blood of Man. Int Arch Allergy Immunol 1990;91:175-80.
31. Williams L, Jarai G, Smith A, Finan P. IL-10 expression profiling in human monocytes. J Leukoc Biol 2002;72:800-9.
32. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein beta IG-H3. Scand J Immunol 2001;53:386-92.
33. Song EW, Ouyang N, Horbelt M, Antus B, Wang MH, Exton MS. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000;204:19-28.
34. Topoll HH, Zwadlo G, Lange DE, Sorg C. Phenotypic Dynamics of Macrophage Subsets During Human Gingivitis. J Dent Res 1988;67:685.
35. Mitani K, Fujita H, Kappas A, Sassa S. Heme Oxygenase Is A Positive Acute-Phase Reactant in Human Hep3B Hepatoma-Cells. Blood 1992;79:1255-9.
36. Wagener FADT, van Beurden HE, den Hoff JW, Adema GJ, Figdor CG. The heme-heme oxygenase system: a molecular switch in wound healing. Blood 2003;102:521-8.
37. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002;8: 240-6.
38. Lee TS, Tsai HL, Chau LY. Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta(12,14)-prostaglandin J(2). J Biol Chem 2003;278:19325-30.
39. Møller HJ, Peterslund NA, Graversen JH, Moestrup SK. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 2002;99:378-80.
40. Sulahian TH, Hintz KA, Wardwell K, Guyre PM. Development of an ELISA to measure soluble CD163 in biological fluids. J Immunol Methods 2001;252:25-31.
41. Droste A, Sorg C, Hogger P. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun 1999;256: 110-3.
42. Hintz KA, Rassias AJ, Wardwell K, Moss ML, Morganelli PM, Pioli PA, et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol 2002;72:711-7.
43. Moestrup SK, Gliemann J. Binding of Alpha-2-Macroglobulin-Proteinase to the Purified Receptor - Evidence That High Functional AFFinity Is Achieved by Binding to Adjacent Receptors. Biol Chem Hoppe-Seyler 1991;372:142.
44. Frings W, Dreier J, Sorg C. Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect. FEBS Lett 2002;526:93-6.
45. Hogger P, Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 2001;288:841-3.
46. Matsushita N, Kashiwagi M, Wait R, Nagayoshi R, Nakamura M, Matsuda T, et al. Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Clin Exp Immunol 2002;130:156-61.
47. Matsuyama T. Elevated levels of functional soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3. Arthritis Rheum 2002;46:S422-S423.
48. Goldstein JI, Goldstein KA, Wardwell K, Fahrner SL, Goonan KE, Cheney MD, et al. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. FASEB J 2003;17:C48.
49. Møller HJ, de Fost M, Aerts H, Hollak C, Moestrup SK. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur J Haematol 2004;72:135-9.
50. Baeten D, Møller HJ, Delanghe JR, Veys EM, Moestrup SK, De Keyser F. CD163+ macrophages and local production of soluble CD163 are associated with lower lymphocyte activation in spondyloarthropathy synovitis. Arthritis Rheum 2004:In press.
51. Møller HJ, Petersen PH, Rejnmark L, Moestrup SK. Biological variation of soluble CD163. Scand J Clin Lab Invest 2003;63:15-21.
52. Walter RB, Bachli EB, Schaer DJ, Ruegg R, Schoedon G. Expression of the hemoglobin scavenger receptor (CD163/ HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia. Blood 2003;101:3755-6.
53. Hotchkiss RS, Karl IE. Medical progress: The pathophysiology and treatment of sepsis. New Engl J Med 2003;48:138-50.